Scarica l'app Stockscreener
18.30
0.71%
-0.13
Dopo l'orario di chiusura:
18.41
0.11
+0.60%
Precedente Chiudi:
$18.43
Aprire:
$18.33
Volume 24 ore:
357.53K
Relative Volume:
1.53
Capitalizzazione di mercato:
$283.46M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-17.23%
1M Prestazione:
-9.76%
6M Prestazione:
-8.91%
1 anno Prestazione:
-20.85%
Intervallo 1D:
$18.13
$19.23
Intervallo di 1 settimana:
$18.13
$22.99
Portata 52W:
$6.875
$37.27
Neurogene Inc Stock (NGNE) Company Profile
Nome
Neurogene Inc
Settore
Industria
Telefono
(877) 237-5020
Indirizzo
535 W 24TH STREET, NEW YORK
Confronta NGNE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NGNE
Neurogene Inc
|
18.30 | 285.48M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Neurogene Inc Stock (NGNE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-17 | Iniziato | Craig Hallum | Buy |
| 2025-05-16 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-06-27 | Iniziato | BMO Capital Markets | Outperform |
| 2024-06-11 | Iniziato | Robert W. Baird | Outperform |
| 2024-04-29 | Iniziato | Leerink Partners | Outperform |
| 2024-03-21 | Iniziato | William Blair | Outperform |
| 2024-01-08 | Iniziato | H.C. Wainwright | Buy |
| 2024-01-05 | Iniziato | Stifel | Buy |
| 2024-01-04 | Iniziato | TD Cowen | Outperform |
Mostra tutto
Neurogene Inc Borsa (NGNE) Ultime notizie
What analysts say about Neurogene Inc UU8 stockStock Liquidity Analysis & Free Stock Predictions and Analysis - earlytimes.in
Neurogene to Participate in the 44th Annual J.P. Morgan Healthcare Conference - Bluefield Daily Telegraph
Genetic medicines firm Neurogene opens its health conference talk online - Stock Titan
Pullback Watch: Is Neurogene Inc stock a good choice for value investorsJuly 2025 Retail & AI Enhanced Trading Signals - moha.gov.vn
Breakout Move: How Applied Industrial Technologies Inc AT4 stock reacts to monetary easingTrend Reversal & Safe Swing Trade Setup Alerts - moha.gov.vn
Here's Why We're Not Too Worried About Neurogene's (NASDAQ:NGNE) Cash Burn Situation - Sahm
Neurogene Inc. (NASDAQ:NGNE) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Neurogene Inc. (NASDAQ:NGNE) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
What catalysts could drive Neurogene Inc. stock higherPortfolio Diversification Tips & Free Hedging Tactics for Volatile Markets - bollywoodhelpline.com
Sell Signal: Is Neurogene Inc stock gaining market shareJuly 2025 Sentiment & Low Risk High Reward Ideas - moha.gov.vn
Earnings Beat: Is Neurogene Inc stock a good choice for value investorsQuarterly Portfolio Summary & Verified Entry Point Signals - moha.gov.vn
Will Neurogene Inc. stock benefit from upcoming earnings reportsWeekly Profit Report & Low Risk Entry Point Tips - Улправда
Why Neurogene Inc. stock appeals to dividend seekersQuarterly Profit Summary & Weekly Breakout Watchlists - Улправда
Will Neurogene Inc. stock gain from lower inflationWeekly Trade Report & Daily Price Action Insights - DonanımHaber
Is Neurogene Inc. stock gaining market shareJuly 2025 Chart Watch & AI Optimized Trade Strategies - DonanımHaber
Can Neurogene Inc. stock continue upward trend2025 Key Highlights & Expert Verified Movement Alerts - DonanımHaber
Will Neurogene Inc. stock split again soonJuly 2025 Retail & Real-Time Volume Analysis Alerts - Улправда
Will Neurogene Inc. (UU8) stock benefit from Fed rate cutsRecession Risk & AI Powered Market Entry Ideas - DonanımHaber
Momentum Shift: Why Neurogene Inc. stock appeals to dividend seekersWeekly Trade Summary & Weekly High Return Opportunities - Улправда
Can Neurogene Inc. stock maintain operating marginsMarket Risk Report & Precise Trade Entry Recommendations - ulpravda.ru
Can Neurogene Inc. stock deliver surprise earnings beatWeekly Earnings Recap & Risk Managed Trade Strategies - Улправда
Insider Buy: Why Neurogene Inc. stock appeals to dividend seekersQuarterly Portfolio Report & Advanced Technical Analysis Signals - Улправда
Neurogene (NASDAQ:NGNE) Lowered to Sell Rating by Wall Street Zen - MarketBeat
Contrasting Neurogene (NASDAQ:NGNE) & Aligos Therapeutics (NASDAQ:ALGS) - Defense World
Entry Recap: Why Neurogene Inc stock appeals to dividend seekersMarket Trend Summary & Reliable Trade Execution Plans - moha.gov.vn
How Neurogene Inc. stock reacts to job market dataMarket Sentiment Report & Safe Swing Trade Setups - Newser
Will Neurogene Inc. (UU8) stock rise with strong economyEarnings Growth Summary & Weekly Market Pulse Updates - Newser
Will Neurogene Inc. (UU8) stock keep high P E multiplesCPI Data & Low Volatility Stock Recommendations - Newser
Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Neurogene (Nasdaq: NGNE) approves inducement stock options for 4,860 shares - Stock Titan
Swing Trade: Can Neurogene Inc stock deliver surprise earnings beatJuly 2025 Retail & Weekly High Momentum Picks - moha.gov.vn
Will Neurogene Inc. (UU8) stock outperform value peers2025 Bull vs Bear & Real-Time Volume Analysis - Newser
Will Neurogene Inc. (UU8) stock profit from automation waveJuly 2025 Catalysts & Weekly High Momentum Picks - Newser
Gene therapy NGN-401 leads to functional gains in Rett syndrome - Rett Syndrome News
Analysts Set Neurogene Inc. (NASDAQ:NGNE) Target Price at $42.50 - Defense World
Is Neurogene Inc. (UU8) stock safe for risk averse investorsJuly 2025 Rallies & Short-Term High Return Strategies - Newser
Is Neurogene Inc. (UU8) stock inflation resilientQuarterly Performance Summary & Risk Managed Trade Strategies - Newser
How institutional buying supports Neurogene Inc. stock2025 Market Sentiment & Verified Technical Trade Signals - Newser
Will Neurogene Inc. (UU8) stock outperform benchmarksJuly 2025 EndofMonth & Community Consensus Stock Picks - Newser
Neurogene (NGNE) Stock Analysis Report | Financials & Insights - Benzinga
Neurogene Inc. (NASDAQ:NGNE) Given Average Rating of "Hold" by Brokerages - MarketBeat
How Neurogene Inc. (UU8) stock correlates with oil markets2025 Geopolitical Influence & Technical Pattern Recognition Alerts - BỘ NỘI VỤ
Is Neurogene Inc a good long term investmentPortfolio Diversification Tips & Small Budget Wealth Tips - earlytimes.in
Wall Street analysts’ outlook for Neurogene Inc (NGNE) - Setenews
Companies Like Neurogene (NASDAQ:NGNE) Are In A Position To Invest In Growth - Yahoo Finance
Neurogene: From Speculation To Execution With NGN-401 (NASDAQ:NGNE) - Seeking Alpha
EBIT per share of Neurogene Inc. – FWB:UU8 - TradingView
Neurogene (NGNE) Price Target Increased by 11.85% to 60.18 - MSN
Neurogene Inc Stock Analysis and ForecastTake Profit Strategies & Start Your Free Trading Journey Today - earlytimes.in
How Neurogene Inc. (UU8) stock reacts to Fed tighteningWeekly Market Outlook & Weekly Chart Analysis and Trade Guides - newser.com
Statistical indicators supporting Neurogene Inc.’s strengthJuly 2025 Opening Moves & Entry and Exit Point Strategies - newser.com
Neurogene Inc Azioni (NGNE) Dati Finanziari
Non sono disponibili dati finanziari per Neurogene Inc (NGNE). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
2.52%
0.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):